Literature DB >> 27031491

Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study.

Amy Clements-Cortes1,2,3,4, Heidi Ahonen2, Michael Evans3, Morris Freedman4, Lee Bartel1.   

Abstract

This study assessed the effect of stimulating the somatosensory system of Alzheimer's disease (AD) patients at three stages of their illness with 40 Hz sound. In this AB cross-over study design, 18 participants (6 mild, 6 moderate, 6 severe) each participated in 13 sessions: one intake and 12 treatment. Treatment A consisted of 40 Hz sound stimulation and Treatment B consisted of visual stimulation using DVDs, each provided twice a week over 6 weeks for a total of 6 times per treatment. Outcome measures included: St. Louis University Mental Status Test (SLUMS), Observed Emotion Rating Scale, and behavioral observation by the researcher. Data were submitted to regression analysis for the series of 6 SLUMS scores in treatment A and 6 scores in B with comparison by group. The slopes for the full sample and subgroups in the 40 Hz treatment were all significant beyond alpha = 0.05, while those for the DVD were not. A thematic analysis of qualitative observations supported the statistical findings. 40 Hz treatment appeared to have the strongest impact on persons with mild and moderate AD. Results are promising in terms of a potential new treatment for persons with AD, and further research is needed.

Entities:  

Keywords:  Alzheimer’s disease; auditory stimulation; cognition; vibration

Mesh:

Year:  2016        PMID: 27031491     DOI: 10.3233/JAD-160081

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  14 in total

1.  Improving autobiographical memory in Alzheimer's disease by transcranial alternating current stimulation.

Authors:  Lucie Bréchet; Christoph M Michel; Daniel L Schacter; Alvaro Pascual-Leone
Journal:  Curr Opin Behav Sci       Date:  2021-02-14

Review 2.  Tactile Low Frequency Vibration in Dementia Management: A Scoping Review.

Authors:  Elsa A Campbell; Jiří Kantor; Lucia Kantorová; Zuzana Svobodová; Thomas Wosch
Journal:  Front Psychol       Date:  2022-06-17

3.  Targeting Gamma-Related Pathophysiology in Autism Spectrum Disorder Using Transcranial Electrical Stimulation: Opportunities and Challenges.

Authors:  Fae B Kayarian; Ali Jannati; Alexander Rotenberg; Emiliano Santarnecchi
Journal:  Autism Res       Date:  2020-05-28       Impact factor: 5.216

Review 4.  The Role of Gamma Oscillations in the Pathophysiology of Substance Use Disorders.

Authors:  Jessica U Ramlakhan; Ming Ma; Reza Zomorrodi; Daniel M Blumberger; Yoshihiro Noda; Mera S Barr
Journal:  J Pers Med       Date:  2020-12-28

Review 5.  Gamma Oscillations in Alzheimer's Disease and Their Potential Therapeutic Role.

Authors:  Artemis Traikapi; Nikos Konstantinou
Journal:  Front Syst Neurosci       Date:  2021-12-13

6.  Investigating the Effects of Auditory and Vibrotactile Rhythmic Sensory Stimulation on Depression: An EEG Pilot Study.

Authors:  Abdullah A Mosabbir; Thenile Braun Janzen; Maryam Al Shirawi; Susan Rotzinger; Sidney H Kennedy; Faranak Farzan; Jed Meltzer; Lee Bartel
Journal:  Cureus       Date:  2022-02-24

Review 7.  Possible Mechanisms for the Effects of Sound Vibration on Human Health.

Authors:  Lee Bartel; Abdullah Mosabbir
Journal:  Healthcare (Basel)       Date:  2021-05-18

Review 8.  Are We Doing More Than We Know? Possible Mechanisms of Response to Music Therapy.

Authors:  Amy Clements-Cortes; Lee Bartel
Journal:  Front Med (Lausanne)       Date:  2018-09-11

9.  Gamma Band Neural Stimulation in Humans and the Promise of a New Modality to Prevent and Treat Alzheimer's Disease.

Authors:  Barry McDermott; Emily Porter; Diarmaid Hughes; Brian McGinley; Mark Lang; Martin O'Halloran; Marggie Jones
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Multi-mechanical waves against Alzheimer's disease pathology: a systematic review.

Authors:  Francisca Monteiro; Ioannis Sotiropoulos; Óscar Carvalho; Nuno Sousa; Filipe S Silva
Journal:  Transl Neurodegener       Date:  2021-09-24       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.